• CDC News
  • Adult Immunization
  • Hepatology
  • Rare Disorders
  • Pediatric Immunization
  • Weight Management
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Kidney Disease
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Orthopedics
  • Obesity Medicine
  • Rheumatology
  • Technology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

3 Diabetes Case Challenges: Choose the Next Best Rx

News
Slideshow

These 3 case studies illustrate the challenges of intensifying treatment in complex T2D patients--and also the options available to individualize that next step.

There is significant flexibility now available when it comes to intensifying pharmacologic treatment for patients with type 2 diabetes (T2D). There is also a growing opportunity to individualize T2D treatment, both when changes to a regimen are needed and at initiation of medical therapy.The following 3 patient case studies illustrate a number of the common comorbidities and complications associated with T2D that make effective management like working on a jigsaw puzzle. With recent FDA label expansions for several classes of T2D drugs, however, it is getting easier to find a perfect fit.Based on your knowledge of the drugs and the science, what is the best next Rx for each of these patients - and why?

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2025 MJH Life Sciences

All rights reserved.